Your Source for Venture Capital and Private Equity Financings

Venture Capital News: Superluminal Medicines Launches with $33M Seed Round

2023-08-29
BOSTON, MA, Superluminal Medicines, a generative biology and chemistry company, announced the closing of a $33 million funding round.
Superluminal Medicines Inc., a generative biology and chemistry company developing a differentiated pipeline and revolutionizing the speed and accuracy of how medicine is created, announced the closing of a $33 million funding round. The investment was led by RA Capital Management with significant participation from Insight Partners and NVIDIA. Gaingels also joined in the financing.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors